Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Patient recruitment ongoing in phase I study of BOS-475

May 31, 2019

Results of phase IIb trial of topical PAC-14028, a TRPV1 antagonist, in atopic dermatitis

May 28, 2019

Aclaris Therapeutics patents JAK1 and JAK3 inhibitors

May 27, 2019

Toray Industries divulges RORC antagonists

May 22, 2019

FLX Bio presents a novel CCR4 antagonist for the treatment of allergic disorders

May 21, 2019

Proof of concept achieved for KB-103 as topical treatment for epidermolysis bullosa dystrophica

May 17, 2019

Phase III study of abrocitinib in atopic dermatitis meets all coprimary and secondary endpoints

May 15, 2019

Sienna reports biopsy data from phase IIb study of SNA-120 for psoriasis

May 15, 2019

Gene editing restores skin functionality in blistering disease

May 13, 2019

Connect Biopharma reports phase I data and new study in atopic dermatitis with CBP-201

May 6, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...